Follow
Chee-Keng Mok
Chee-Keng Mok
Biosafety Level 3 Platform, A*STAR Infectious Diseases Labs
Verified email at idlabs.a-star.edu.sg - Homepage
Title
Cited by
Cited by
Year
Genomic signatures of human versus avian influenza A viruses
GW Chen, SC Chang, CK Mok, YL Lo, YN Kung, JH Huang, YH Shih, ...
Emerging infectious diseases 12 (9), 1353, 2006
3142006
Laboratory-based surveillance and molecular epidemiology of influenza virus in Taiwan
SR Shih, GW Chen, CC Yang, WZ Yang, DP Liu, JH Lin, SC Chiu, ...
Journal of clinical microbiology 43 (4), 1651-1661, 2005
902005
Calcitriol, the active form of vitamin D, is a promising candidate for COVID-19 prophylaxis
CK Mok, YL Ng, BA Ahidjo, RC Hua Lee, MW Choy Loe, J Liu, KS Tan, ...
BioRxiv, 2020.06. 21.162396, 2020
582020
Current perspective of antiviral strategies against COVID-19
BA Ahidjo, MWC Loe, YL Ng, CK Mok, JJH Chu
ACS infectious diseases 6 (7), 1624-1634, 2020
542020
Antiviral natural products for arbovirus infections
VSL Goh, CK Mok, JJH Chu
Molecules 25 (12), 2796, 2020
502020
Airborne SARS‐CoV‐2 surveillance in hospital environment using high‐flowrate air samplers and its comparison to surface sampling
AXY Ang, I Luhung, BA Ahidjo, DI Drautz‐Moses, PA Tambyah, CK Mok, ...
Indoor Air 32 (1), e12930, 2022
302022
Systematic phylogenetic analysis of influenza A virus reveals many novel mosaic genome segments
TTY Lam, YL Chong, M Shi, CC Hon, J Li, DP Martin, JWT Tang, CK Mok, ...
Infection, Genetics and Evolution 18, 367-378, 2013
272013
Pyrosequencing reveals an oseltamivir-resistant marker in the quasispecies of avian influenza A (H7N9) virus
CK Mok, SC Chang, GW Chen, YL Lo, SJ Chen, HS Wu, MT Liu, ...
Journal of Microbiology, Immunology and Infection 48 (4), 465-469, 2015
182015
False positive antibody results against human T‐cell lymphotropic virus in patients with severe acute respiratory syndrome
KC Tsao, GW Chen, CG Huang, YL Huang, JY Lin, MC Keng, CF Sun, ...
Journal of medical virology 77 (3), 331-336, 2005
182005
A blood RNA transcriptome signature for COVID-19
PKW Kwan, GB Cross, CM Naftalin, BA Ahidjo, CK Mok, F Fanusi, ...
BMC medical genomics 14, 1-8, 2021
162021
A potent and protective human neutralizing antibody against SARS-CoV-2 variants
S Shan, CK Mok, S Zhang, J Lan, J Li, Z Yang, R Wang, L Cheng, M Fang, ...
Frontiers in immunology 12, 766821, 2021
142021
Influenza A/B virus detection and influenza A virus subtyping with emphasis on the novel H7N9 virus by using multiplex real-time RT-PCR
RL Kuo, SL Yang, YC Liu, LT Chen, CK Mok, SM Kuo, SR Shih, KC Tsao
Journal of virological methods 208, 41-46, 2014
122014
Altered pathogenicity for seasonal influenza virus by single reassortment of the RNP genes derived from the 2009 pandemic influenza virus
EF Hsieh, SJ Lin, CK Mok, GW Chen, CH Huang, YC Wang, TC Chen, ...
Journal of Infectious Diseases 204 (6), 864-872, 2011
112011
A cross-clade H5N1 influenza A virus neutralizing monoclonal antibody binds to a novel epitope within the vestigial esterase domain of hemagglutinin
SS Paul, CK Mok, TM Mak, OW Ng, JO Aboagye, TJ Wohlbold, F Krammer, ...
Antiviral research 144, 299-310, 2017
92017
A monoclonal antibody binds to threonine 49 in the non-structural 1 protein of influenza A virus and interferes with its ability to modulate viral replication
B Barnwal, CK Mok, J Wu, MK Diwakar, G Gupta, Q Zeng, VTK Chow, ...
Antiviral Research 116, 55-61, 2015
72015
Adenovirus vectored IFN-α protects mice from lethal challenge of Chikungunya virus infection
H Chen, N Min, L Ma, CK Mok, JJH Chu
PLOS Neglected Tropical Diseases 14 (12), e0008910, 2020
62020
Evolutionarily conserved residues at an oligomerization interface of the influenza A virus neuraminidase are essential for viral survival
CK Mok, GW Chen, KC Shih, YN Gong, SJ Lin, JT Horng, JTA Hsu, ...
Virology 447 (1-2), 32-44, 2013
62013
Evaluation of in vitro and in vivo antiviral activities of vitamin D for SARS-CoV-2 and variants
CK Mok, YL Ng, BA Ahidjo, ZQ Aw, H Chen, YH Wong, RCH Lee, ...
Pharmaceutics 15 (3), 925, 2023
52023
Contribution of Fc-dependent cell-mediated activity of a vestigial esterase-targeting antibody against H5N6 virus infection
Z Zheng, SHC Teo, SC Arularasu, Z Liu, NK Mohd-Ismail, CK Mok, ...
Emerging Microbes & Infections 9 (1), 95-110, 2020
52020
AAV-CRISPR-Cas13 eliminates human enterovirus and prevents death of infected mice
CT Keng, T Yogarajah, RCH Lee, IBH Muhammad, BS Chia, ...
EBioMedicine 93, 2023
42023
The system can't perform the operation now. Try again later.
Articles 1–20